Xuanzhu Biopharmaceutical Co Ltd

NEW
FRA:V59 (China)   Ordinary Shares-Class H
€ 1.306 +0.038 (+3%) Aug 7
At Loss
P/B:
4.27
Market Cap:
€ 715.03M ($ 825.34M)
Enterprise V:
€ 631.26M ($ 728.64M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Xuanzhu Biopharmaceutical Co Ltd Valuation Measures